Instem and Sable Bio Launch Partnership to Accelerate Target Risk Assessment Through AI-Powered Scientific Intelligence

Contributed by: Business Wire

Logo

Tags

Technology

Research

Health Technology

Software

Biotechnology

Health

Pharmaceutical

Science

Artificial Intelligence

Instem

More Like This

Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs

Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution

INSTEM Announces Extension of Research Collaboration Agreement with U.S. FDA to 2031

Instem Unveils New Global Headquarters in Boston, MA

PR Newswire associated0

TetraScience Launches Scientific AI Lighthouse Program with Takeda as Founding Partner

Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery